Drug
Psilocybin (high dose)
Psilocybin (high dose) is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_1
1
33%
Ph phase_2
2
67%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
enrolling_by_invitation133%
recruiting267%
Recent Activity
Clinical Trials (3)
Showing 3 of 3 trials
NCT06810310Phase 2
Psilocybin on Brain Mechanisms of Motivation in OUD
NCT07180108Phase 1
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
NCT06160232Phase 2
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3